This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boeckh, M.
Right arrow Articles by Boivin, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boeckh, M.
Right arrow Articles by Boivin, G.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, July 1998, p. 533-554, Vol. 11, No. 3
0893-8512/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Quantitation of Cytomegalovirus: Methodologic Aspects and Clinical Applications

Michael Boeckh1,* and Guy Boivin2

Fred Hutchinson Cancer Research Center, Seattle, Washington,1 and Centre Hospitalier de l'Université Laval, Sainte-Foy, Quebec, Canada2

Cytomegalovirus (CMV) is an important pathogen in transplant recipients and human immunodeficiency virus (HIV)-infected individuals. Major progress has been made in developing quantitative detection methods for CMV in recent years. Due to their high sensitivity, these assays can detect CMV early, and quantitation may be useful in predicting the patient's risk for disease and in monitoring the effect of antiviral therapy. This review discusses methodological aspects of currently used quantitative assays for CMV (i.e., viral culture techniques, antigen detection assays, DNA detection assays including PCR, branched-DNA assay, and the DNA hybrid capture assay) and addresses the correlation of systemic and site-specific CMV load and CMV disease in different populations of immunosuppressed patients as well as the response to antiviral treatment. To date, direct antigen detection and molecular techniques have largely replaced traditional culture-based techniques for CMV quantitation. In general, a high systemic CMV load is correlated with CMV disease. This correlation is strong in the HIV-infected population and in solid-organ transplant recipients but less clear in allogeneic marrow transplant recipients. Measuring the viral load at specific anatomic sites may be an alternative way to assess disease activity in situations where the systemic viral load correlates poorly with disease activity. A reduction of the systemic CMV load also correlates with a response to antiviral treatment, but more research is needed to evaluate the role of viral load as a surrogate marker for drug resistance. Due to the widespread use of quantitative CMV detection techniques to direct and monitor antiviral treatment, there is a great need for an assessment of the reproducibility of test results and better standardization of the assays.

* Corresponding author. Mailing address: Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. North, Seattle, WA 98109. Phone: (206) 667-6702. Fax: (206) 667-4411. E-mail: mboeckh{at}fhcrc.org.

Clinical Microbiology Reviews, July 1998, p. 533-554, Vol. 11, No. 3
0893-8512/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Boeckh, M., Ljungman, P. (2009). How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood 113: 5711-5719 [Abstract] [Full Text]  
  • Takizawa, Y., Inokuma, S., Tanaka, Y., Saito, K., Atsumi, T., Hirakata, M., Kameda, H., Hirohata, S., Kondo, H., Kumagai, S., Tanaka, Y. (2008). Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population. Rheumatology (Oxford) 47: 1373-1378 [Abstract] [Full Text]  
  • Garrigue, I., Doussau, A., Asselineau, J., Bricout, H., Couzi, L., Rio, C., Merville, P., Fleury, H., Lafon, M.-E., Thiebaut, R. (2008). Prediction of Cytomegalovirus (CMV) Plasma Load from Evaluation of CMV Whole-Blood Load in Samples from Renal Transplant Recipients. J. Clin. Microbiol. 46: 493-498 [Abstract] [Full Text]  
  • Leland, D. S., Ginocchio, C. C. (2007). Role of Cell Culture for Virus Detection in the Age of Technology. Clin. Microbiol. Rev. 20: 49-78 [Abstract] [Full Text]  
  • Ueno, T., Eizuru, Y., Katano, H., Kurata, T., Sata, T., Irie, S., Ogawa-Goto, K. (2006). Novel Real-Time Monitoring System for Human Cytomegalovirus- Infected Cells In Vitro That Uses a Green Fluorescent Protein-PML-Expressing Cell Line. Antimicrob. Agents Chemother. 50: 2806-2813 [Abstract] [Full Text]  
  • Dummer, S. (2005). Controlling the Troll: Management of Cytomegalovirus Infection after Transplantation. ANN INTERN MED 143: 913-914 [Full Text]  
  • Wirgart, B. Z., Andersson, P., Grillner, L. (2005). Evaluation of the ReSSQ Assay in Relation to the COBAS AMPLICOR CMV MONITOR Test and an In-House Nested PCR Method for Detection of Cytomegalovirus DNA. J. Clin. Microbiol. 43: 4057-4063 [Abstract] [Full Text]  
  • Gilbert, C., Boivin, G. (2005). Human Cytomegalovirus Resistance to Antiviral Drugs. Antimicrob. Agents Chemother. 49: 873-883 [Full Text]  
  • Herrmann, B., Cavaglia Larsson, V., Rubin, C.-J., Sund, F., Eriksson, B.-M., Arvidson, J., Yun, Z., Bondeson, K., Blomberg, J. (2004). Comparison of a Duplex Quantitative Real-Time PCR Assay and the COBAS Amplicor CMV Monitor Test for Detection of Cytomegalovirus. J. Clin. Microbiol. 42: 1909-1914 [Abstract] [Full Text]  
  • Burggraf, S., Olgemoller, B. (2004). Simple Technique for Internal Control of Real-Time Amplification Assays. Clin. Chem. 50: 819-825 [Abstract] [Full Text]  
  • Kalpoe, J. S., Kroes, A. C. M., de Jong, M. D., Schinkel, J., de Brouwer, C. S., Beersma, M. F. C., Claas, E. C. J. (2004). Validation of Clinical Application of Cytomegalovirus Plasma DNA Load Measurement and Definition of Treatment Criteria by Analysis of Correlation to Antigen Detection. J. Clin. Microbiol. 42: 1498-1504 [Abstract] [Full Text]  
  • Boeckh, M., Huang, M., Ferrenberg, J., Stevens-Ayers, T., Stensland, L., Nichols, W. G., Corey, L. (2004). Optimization of Quantitative Detection of Cytomegalovirus DNA in Plasma by Real-Time PCR. J. Clin. Microbiol. 42: 1142-1148 [Abstract] [Full Text]  
  • Meijer, E., Boland, G. J., Verdonck, L. F. (2003). Prevention of Cytomegalovirus Disease in Recipients of Allogeneic Stem Cell Transplants. Clin. Microbiol. Rev. 16: 647-657 [Abstract] [Full Text]  
  • Pang, X. L., Chui, L., Fenton, J., LeBlanc, B., Preiksaitis, J. K. (2003). Comparison of LightCycler-Based PCR, COBAS Amplicor CMV Monitor, and pp65 Antigenemia Assays for Quantitative Measurement of Cytomegalovirus Viral Load in Peripheral Blood Specimens from Patients after Solid Organ Transplantation. J. Clin. Microbiol. 41: 3167-3174 [Abstract] [Full Text]  
  • Gerna, G., Lilleri, D., Baldanti, F., Torsellini, M., Giorgiani, G., Zecca, M., De Stefano, P., Middeldorp, J., Locatelli, F., Revello, M. G. (2003). Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial. Blood 101: 5053-5060 [Abstract] [Full Text]  
  • Li, H., Dummer, J. S., Estes, W. R., Meng, S., Wright, P. F., Tang, Y.-W. (2003). Measurement of Human Cytomegalovirus Loads by Quantitative Real-Time PCR for Monitoring Clinical Intervention in Transplant Recipients. J. Clin. Microbiol. 41: 187-191 [Abstract] [Full Text]  
  • Stocher, M., Berg, J. (2002). Normalized Quantification of Human Cytomegalovirus DNA by Competitive Real-Time PCR on the LightCycler Instrument. J. Clin. Microbiol. 40: 4547-4553 [Abstract] [Full Text]  
  • Boom, R., Sol, C. J. A., Schuurman, T., van Breda, A., Weel, J. F. L., Beld, M., ten Berge, I. J. M., Wertheim-van Dillen, P. M. E, de Jong, M. D. (2002). Human Cytomegalovirus DNA in Plasma and Serum Specimens of Renal Transplant Recipients Is Highly Fragmented. J. Clin. Microbiol. 40: 4105-4113 [Abstract] [Full Text]  
  • Revello, M. G., Gerna, G. (2002). Diagnosis and Management of Human Cytomegalovirus Infection in the Mother, Fetus, and Newborn Infant. Clin. Microbiol. Rev. 15: 680-715 [Abstract] [Full Text]  
  • Bryant, P, Morley, C, Garland, S, Curtis, N (2002). Cytomegalovirus transmission from breast milk in premature babies: does it matter?. Arch. Dis. Child. Fetal Neonatal Ed. 87: F75-77 [Abstract] [Full Text]  
  • Sanchez, J. L., Storch, G. A. (2002). Multiplex, Quantitative, Real-Time PCR Assay for Cytomegalovirus and Human DNA. J. Clin. Microbiol. 40: 2381-2386 [Abstract] [Full Text]  
  • Berger, A., Preiser, W. (2002). Viral genome quantification as a tool for improving patient management: the example of HIV, HBV, HCV and CMV. J Antimicrob Chemother 49: 713-721 [Abstract] [Full Text]  
  • von Muller, L., Hampl, W., Hinz, J., Meisel, H., Reip, A., Engelmann, E., Heilbronn, R., Gartner, B., Kramer, O., Einsele, H., Hebart, H., Ljubicic, T., Loffler, J., Mertens, T. (2002). High Variability between Results of Different In-House Tests for Cytomegalovirus (CMV) Monitoring and a Standardized Quantitative Plasma CMV PCR Assay. J. Clin. Microbiol. 40: 2285-2287 [Abstract] [Full Text]  
  • Gouarin, S., Gault, E., Vabret, A., Cointe, D., Rozenberg, F., Grangeot-Keros, L., Barjot, P., Garbarg-Chenon, A., Lebon, P., Freymuth, F. (2002). Real-Time PCR Quantification of Human Cytomegalovirus DNA in Amniotic Fluid Samples from Mothers with Primary Infection. J. Clin. Microbiol. 40: 1767-1772 [Abstract] [Full Text]  
  • Brumble, L. M., Milstone, A. P., Loyd, J. E., Ely, E. W., Pierson, R. N. III, Gautam, S., Dummer, J. S. (2002). Prevention of Cytomegalovirus Infection and Disease After Lung Transplantation : Results Using a Unique Regimen Employing Delayed Ganciclovir. Chest 121: 407-414 [Abstract] [Full Text]  
  • Razonable, R. R., Brown, R. A., Espy, M. J., Rivero, A., Kremers, W., Wilson, J., Groettum, C., Smith, T. F., Paya, C. V. (2001). Comparative Quantitation of Cytomegalovirus (CMV) DNA in Solid Organ Transplant Recipients with CMV Infection by Using Two High-Throughput Automated Systems. J. Clin. Microbiol. 39: 4472-4476 [Abstract] [Full Text]  
  • Castagnola, E., Miano, M., Morreale, G., Cristina, E., Chierici, M., Lanino, E., Ljungman, P., Cordonnier, C., Nichols, W. G., Boeckh, M. (2001). Strategies for management of cytomegalovirus (CMV) infection after allogeneic bone marrow transplantation: the "doubling of baseline CMV pp65 antigenemia" and the "cidofovir as rescue treatment" approaches. Blood 98: 1627-1630 [Full Text]  
  • Lang, D., Vornhagen, R., Rothe, M., Hinderer, W., Sonneborn, H.-H., Plachter, B. (2001). Cross-Reactivity of Epstein-Barr Virus-Specific Immunoglobulin M Antibodies with Cytomegalovirus Antigens Containing Glycine Homopolymers. CVI 8: 747-756 [Abstract] [Full Text]  
  • Nichols, W. G., Corey, L., Gooley, T., Drew, W. L., Miner, R., Huang, M.-L., Davis, C., Boeckh, M. (2001). Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes. Blood 97: 867-874 [Abstract] [Full Text]  
  • Gault, E., Michel, Y., Dehee, A., Belabani, C., Nicolas, J.-C., Garbarg-Chenon, A. (2001). Quantification of Human Cytomegalovirus DNA by Real-Time PCR. J. Clin. Microbiol. 39: 772-775 [Abstract] [Full Text]  
  • Greijer, A. E., Verschuuren, E. A. M., Harmsen, M. C., Dekkers, C. A. J., Adriaanse, H. M. A., The, T. H., Middeldorp, J. M. (2001). Direct Quantification of Human Cytomegalovirus Immediate-Early and Late mRNA Levels in Blood of Lung Transplant Recipients by Competitive Nucleic Acid Sequence-Based Amplification. J. Clin. Microbiol. 39: 251-259 [Abstract] [Full Text]  
  • Sullivan, K. M., Dykewicz, C. A., Longworth, D. L., Boeckh, M., Baden, L. R., Rubin, R. H., Sepkowitz, K. A. (2001). Preventing Opportunistic Infections After Hematopoietic Stem Cell Transplantation: The Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and Beyond. ASH Education Book 2001: 392-421 [Abstract] [Full Text]  
  • Boivin, G., Belanger, R., Delage, R., Beliveau, C., Demers, C., Goyette, N., Roy, J. (2000). Quantitative Analysis of Cytomegalovirus (CMV) Viremia Using the pp65 Antigenemia Assay and the COBAS AMPLICOR CMV MONITOR PCR Test after Blood and Marrow Allogeneic Transplantation. J. Clin. Microbiol. 38: 4356-4360 [Abstract] [Full Text]  
  • Riise, G. C., Andersson, R., Bergstrom, T., Lundmark, A., Nilsson, F. N., Olofsson, S. (2000). Quantification of Cytomegalovirus DNA in BAL Fluid : A Longitudinal Study in Lung Transplant Recipients. Chest 118: 1653-1660 [Abstract] [Full Text]  
  • Bai, X., Rogers, B. B., Harkins, P. C., Sommerauer, J., Squires, R., Rotondo, K., Quan, A., Dawson, D. B., Scheuermann, R. H. (2000). Predictive Value of Quantitative PCR-Based Viral Burden Analysis for Eight Human Herpesviruses in Pediatric Solid Organ Transplant Patients. J. Mol. Diagn. 2: 191-201 [Abstract] [Full Text]  
  • Poirier-Toulemonde, A.-S., Milpied, N., Cantarovich, D., Morcet, J.-F., Billaudel, S., Imbert-Marcille, B.-M. (2000). Clinical Relevance of Direct Quantification of pp65 Antigenemia Using Flow Cytometry in Solid Organ and Stem Cell Transplant Recipients. J. Clin. Microbiol. 38: 3143-3149 [Abstract] [Full Text]  
  • Schafer, P., Tenschert, W., Schroter, M., Gutensohn, K., Laufs, R. (2000). False-Positive Results of Plasma PCR for Cytomegalovirus DNA due to Delayed Sample Preparation. J. Clin. Microbiol. 38: 3249-3253 [Abstract] [Full Text]  
  • Nulens, E., Bodeus, M., Bonelli, F., Soleti, A., Goubau, P. (2000). Reactivity to p52 and CM2 Recombinant Proteins in Primary Human Cytomegalovirus Infection with a Microparticle Agglutination Assay. CVI 7: 536-539 [Abstract] [Full Text]  
  • Clementi, M. (2000). Quantitative Molecular Analysis of Virus Expression and Replication. J. Clin. Microbiol. 38: 2030-2036 [Full Text]  
  • Alvarez-Barrientos, A., Arroyo, J., Canton, R., Nombela, C., Sanchez-Perez, M. (2000). Applications of Flow Cytometry to Clinical Microbiology. Clin. Microbiol. Rev. 13: 167-195 [Abstract] [Full Text]  
  • Tong, C. Y. W., Cuevas, L. E., Williams, H., Bakran, A. (2000). Comparison of Two Commercial Methods for Measurement of Cytomegalovirus Load in Blood Samples after Renal Transplantation. J. Clin. Microbiol. 38: 1209-1213 [Abstract] [Full Text]  
  • Sia, I. G., Patel, R. (2000). New Strategies for Prevention and Therapy of Cytomegalovirus Infection and Disease in Solid-Organ Transplant Recipients. Clin. Microbiol. Rev. 13: 83-121 [Abstract] [Full Text]  
  • Holmberg, L. A., Boeckh, M., Hooper, H., Leisenring, W., Rowley, S., Heimfeld, S., Press, O., Maloney, D. G., McSweeney, P., Corey, L., Maziarz, R. T., Appelbaum, F. R., Bensinger, W. (1999). Increased Incidence of Cytomegalovirus Disease After Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation. Blood 94: 4029-4035 [Abstract] [Full Text]  
  • Nitsche, A., Steuer, N., Schmidt, C. A., Landt, O., Siegert, W. (1999). Different Real-Time PCR Formats Compared for the Quantitative Detection of Human Cytomegalovirus DNA. Clin. Chem. 45: 1932-1937 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»